Wells Fargo’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,569
Closed -$645K 7578
2022
Q2
$645K Sell
8,569
-149,142
-95% -$11.2M ﹤0.01% 3374
2022
Q1
$4.24M Sell
157,711
-1,204
-0.8% -$32.3K ﹤0.01% 2454
2021
Q4
$7.58M Sell
158,915
-481,234
-75% -$23M ﹤0.01% 2010
2021
Q3
$42.5M Sell
640,149
-7,035
-1% -$467K 0.01% 1142
2021
Q2
$50.5M Buy
647,184
+8,047
+1% +$628K 0.01% 1035
2021
Q1
$60.5M Buy
639,137
+7,637
+1% +$722K 0.01% 922
2020
Q4
$76.9M Buy
631,500
+20,766
+3% +$2.53M 0.02% 759
2020
Q3
$53.4M Buy
610,734
+109,081
+22% +$9.53M 0.01% 834
2020
Q2
$32.4M Buy
501,653
+10,426
+2% +$673K 0.01% 1070
2020
Q1
$21.9M Sell
491,227
-28,092
-5% -$1.25M 0.01% 1174
2019
Q4
$32.3M Sell
519,319
-14,247
-3% -$887K 0.01% 1167
2019
Q3
$20.1M Buy
533,566
+531,784
+29,842% +$20M 0.01% 1436
2019
Q2
$72K Buy
+1,782
New +$72K ﹤0.01% 5176